Immunic Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Immunic, Inc. (IMUX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents35.6746.67106.7586.86127.4529.37
Short-Term Investments0.000.009.630.000.000.00
Cash & Short-Term Investments35.6746.67116.3786.86127.4529.37
Accounts Receivable0.681.372.662.151.640.00
Inventory0.000.000.000.000.000.00
Other Current Assets2.981.071.231.121.230.80
Total Current Assets39.3352.53125.86104.99133.7532.23
Non-Current Assets
Property, Plant & Equipment (Net)1.541.771.851.101.100.71
Goodwill0.000.000.0032.9732.970.00
Other Non-Current Assets0.000.000.040.040.040.04
Total Non-Current Assets1.541.771.8934.1134.1233.73
Total Assets40.8754.30127.75139.10167.8665.96
Current Liabilities
Accounts Payable7.8523.763.753.508.025.72
Short-Term Debt0.740.000.000.000.000.00
Accrued Liabilities12.5617.207.106.404.320.00
Other Current Liabilities13.590.970.240.180.381.35
Total Current Liabilities22.1824.7313.0811.408.407.07
Non-Current Liabilities
Long-Term Debt0.260.640.990.580.680.52
Other Non-Current Liabilities0.000.000.000.000.000.00
Total Non-Current Liabilities0.260.640.990.580.680.52
Total Liabilities22.4425.3714.0711.999.087.59
Stockholders' Equity
Common Stock0.010.000.000.000.000.00
Retained Earnings-511.40-407.14-317.28-196.87-108.01-59.90
Accumulated Other Comprehensive Income4.213.763.04-0.25-4.11-1.37
Additional Paid-in Capital525.61436.06427.93324.24266.82119.65
Shares Outstanding90.1545.1839.3126.340.000.00
Total Stockholders' Equity18.4328.92113.68127.12158.8158.37
Total Liabilities & Equity40.8754.30127.75139.10167.8665.96